Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis
The newer, sirolimus DCB was noninferior on angiography, but additional clinical studies with longer follow-up are needed.
Source: tctmd.com
Stay updated with breaking news from Bruno Scheller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The newer, sirolimus DCB was noninferior on angiography, but additional clinical studies with longer follow-up are needed.
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26